Apollo Hospitals Enterprise is currently trading at Rs. 1278.00, up by 15.50 points or 1.23 % from its previous closing of Rs. 1262.50 on the BSE.
The scrip opened at Rs. 1274.00 and has touched a high and low of Rs. 1283.00 and Rs. 1262.85 respectively. So far 979 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1442.75 on 09-Aug-2016 and a 52 week low of Rs. 1110.75 on 26-Dec-2016.
Last one week high and low of the scrip stood at Rs. 1,340.25 and Rs. 1,257.65 respectively. The current market cap of the company is Rs. 17780.20 crore.
The promoters holding in the company stood at 34.35%, while Institutions and Non-Institutions held 51.43% and 13.42% respectively.
Apollo Hospitals has entered into partnership with Mumbai-based Regenerative Medical Services (RMS) Regrow to offer a safe and cost-effective cell therapy for cartilage and bone problems for the first time in India. The partnership will make the cell-based treatment available across all 40 centres of Apollo Hospitals, including Apollo Spectra Hospitals and Apollo clinics in India.
Apollo Hospitals Enterprise owns and operates chain of multi-specialty hospitals. It offers the services in the area of cardiology, cardiothoracic, orthopedics and joint replacement, spine surgery, oncology, medical and surgical gastroenterology, neurology, neurosurgery, nephrology, urology, cyberknife robotic radio, birmingham hip replacement, cosmetic, bariatric, liver and bone marrow transplants.
Company Name | CMP |
---|---|
Apollo Hospital Ent. | 7032.20 |
Max Healthcare Inst | 1149.45 |
Narayana Hrudayalay | 1311.85 |
Aster DM Healthcare | 503.80 |
Global Health | 1073.55 |
View more.. |